methylnaltrexone and Cancer-Pain

methylnaltrexone has been researched along with Cancer-Pain* in 2 studies

Reviews

1 review(s) available for methylnaltrexone and Cancer-Pain

Article	Year
Management of Opioid-Induced Constipation in Patients with Malignancy. The American journal of medicine, 2018, Volume: 131, Issue:9 Topics: Analgesics, Opioid; Cancer Pain; Constipation; Enema; Gastrointestinal Agents; Gastrostomy; Humans; Laxatives; Morphinans; Naltrexone; Piperidines; Polyethylene Glycols; Practice Guidelines as Topic; Quaternary Ammonium Compounds	2018

Trials

1 trial(s) available for methylnaltrexone and Cancer-Pain

Article	Year
Subcutaneous methylnaltrexone for opioid-induced constipation in advanced-illness patients with or without active cancer. Pain management, 2020, Volume: 10, Issue:2 Topics: Adult; Aged; Cancer Pain; Double-Blind Method; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Induced Constipation; Outcome Assessment, Health Care; Quaternary Ammonium Compounds	2020

Article

Year

Subcutaneous methylnaltrexone for opioid-induced constipation in advanced-illness patients with or without active cancer.

Pain management, 2020, Volume: 10, Issue:2

Topics: Adult; Aged; Cancer Pain; Double-Blind Method; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Induced Constipation; Outcome Assessment, Health Care; Quaternary Ammonium Compounds

2020